Skip to main content
Equibles

FRED ALGER MANAGEMENT, LLC

Position in TENX — Tenax Therapeutics, Inc.

CIK 3520 NEW YORK, NY
Back to TENX Full portfolio

Position in TENX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,047,119
New position
Shares Held
71,967
first reported quarter
Ownership
0.192%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 111 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FRED ALGER MANAGEMENT, LLC holds $805,760,903 across 54 Biotechnology names. TENX ranks #39 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARWR
Arrowhead Pharmaceuticals, Inc.
 3,301,919 $269,139,417
2 DNTH
Dianthus Therapeutics, Inc. /DE/
 1,302,493 $126,967,017
3 TWST
Twist Bioscience Corp
 558,157 $57,423,192
4 RVMD
Revolution Medicines, Inc.
 259,468 $48,593,167
5 ASND
Ascendis Pharma A/S
 171,447 $45,728,343
6 COGT
Cogent Biosciences, Inc.
 1,072,830 $41,518,521
7 ROIV
Roivant Sciences Ltd.
 1,081,421 $38,271,489
8
1,439,697 $30,593,561

All Filings in TENX

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $1,047,119 71,967